Irati Garmendia

8PUBLICATIONS
41CO-AUTHORS
Decision makingSolid tumoursCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 08, 2023
Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment.

Irati Garmendia, Aditi Varthaman, Solenne Marmier

|Oct 14, 2022
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.

Mario Sánchez-Canteli, Luis Juesas, Irati Garmendia

|Jun 22, 2022
YES1: A Novel Therapeutic Target and Biomarker in Cancer.

Irati Garmendia, Esther Redin, Luis M Montuenga

|Nov 17, 2019
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.

Francisco Hermida-Prado, Rocío Granda-Díaz, Nagore Del-Río-Ibisate

|Aug 07, 2019
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.

Francisco Hermida-Prado, M Ángeles Villaronga, Rocío Granda-Díaz

Pageof 2